Dec 23, 2025
Pfizer Reports Patient Death In Marstacimab Hemophilia Extension Study

Pfizer Inc. (NYSE:PFE) disclosed the death of a participant in a long-term open-label extension study of marstacimab in patients with hemophilia A or B. In October 2024, the FDA approved Pfizer’s Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce…

Dec 23, 2025
What’s Going On With BioMarin Stock On Tuesday?

On Friday, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) agreed to acquire Amicus Therapeutics, Inc. (NASDAQ:FOLD) for a total equity value of about $4.8 billion. "Immediately upon close, this transaction is expected to accelerate BioMarin's revenue growth and strengthen our financial outlook, delivering…

Dec 23, 2025
Here’s Why This Analyst Chose Reddit As 2026 Top Pick

Reddit, Inc. (NYSE:RDDT) is leaning into its massive trove of human conversations as demand surges for high-quality AI training data. The platform is also pushing new product features and ad tools as it works to deepen engagement and expand monetization.…

Dec 23, 2025
Starfighters Space Hits Public Markets At Full Throttle

Starfighters Space, Inc. (AMEX:FJET) debuted on the NYSE American last Thursday with its initial public offering (IPO) priced at a modest $3.59 per share.  FJET stock is moving. See the chart and price action here.  The stock has since lived…

Dec 23, 2025
Rocket Lab Is Carving Out SpaceX Rival Status, Analyst Says

Rocket Lab Corporation (NASDAQ:RKLB) is positioning itself as an alternative to SpaceX as customers push for more launch capacity. The company is leaning on its growing space systems business and next-generation Neutron rocket to broaden its reach. Needham analyst Ryan…

Dec 23, 2025
What’s Going On With Eli Lilly Stock Today?

Eli Lilly and Company (NASDAQ:LLY) shares are trading down on Tuesday as investors weigh the competitive landscape in the pharmaceutical sector. Eli Lilly stock is trading near recent highs. What’s next for LLY stock? What To Know: Novo Nordisk, one of…